No change in policy on flu samples: Indonesia (Gulf Times) Indonesia does not intend to resume sharing bird flu samples with other countries until there is a global mechanism for virus sharing in place, the newly appointed health minister said yesterday. [News Source]

Health officials answer common flu questions (The Bakersfield Californian) If you're having a hard time keeping up with the swirl of information surrounding H1N1 (swine) flu, seasonal flu, bird flu and maybe even your chimney flue, you're not alone. So we collected a batch of frequently asked questions and sought out answers. [News Source]

WHO: swine flu deaths rise to nearly 5,000, Glaxo says kids may only need 1 vaccine dose. Nearly 5,000 people have reportedly died from swine flu since it emerged this year and developed into a global epidemic, the World Health Organization said Friday. [News Source]

(AFX UK Focus) 2009-10-24 10:49 Indonesia says no policy change on bird flu samples (Interactive Investor) By Karima Anjani [News Source]

Indonesia says no policy change on bird flu samples (Reuters via Yahoo! News) Indonesia does not intend to resume sharing bird flu samples with other countries until there is a global mechanism for virus sharing in place, the newly appointed health minister told Reuters on Saturday. [News Source]

Indonesia says no policy change on bird flu samples (AlertNet) Source: Reuters By Karima Anjani JAKARTA, Oct 24 (Reuters) - Indonesia does not intend to resume sharing bird flu samples with other countries until there is a global mechanism for virus sharing in place, the newly ... [News Source]

UC Davis starts program to fight pandemic disease (The Daily Democrat) In hopes of preventing the next global pandemic and a possible death toll into the millions, UC Davis on Friday launched an unprecedented international effort to find and control diseases that move between wildlife and people. [News Source]

Cohen Independent Research Group publishes a report profiling Nutra Pharma (News-Medical-Net) Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that Cohen Independent Research Group has published a report profiling Nutra Pharma Corporation. [News Source]